First Experience of Concomitant Vaccination Against Dengue and MMR in Toddlers

Denis Crevat1, Job D Brion, Sophia Gailhardou

  • 1From the *Clinical Department, Sanofi Pasteur, Marcy l'Etoile, France; †San Pablo City Health Office, San Pablo, Philippines; ‡Pharmacovigilance Department, Sanofi Pasteur, Lyon, France; §Clinical Department, Sanofi Pasteur, Makati, Philippines; and ¶Research Institute for Tropical Medicine, Muntinlupa City, Philippines.

Insights

This study shows the recombinant dengue vaccine (CYD-TDV) is safe and effective in toddlers. Coadministration with the measles, mumps, and rubella (MMR) vaccine did not impact its immunogenicity.

Area of Science:

  • Tropical Medicine
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Dengue poses a significant public health threat to children in dengue-endemic areas.
  • A recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV) is being developed for dengue control.
  • The vaccine is administered on a 3-dose schedule (0-6-12 months).

Purpose of the Study:

  • To evaluate the safety and immunogenicity of the CYD-TDV in toddlers.
  • To assess the effects of coadministering CYD-TDV with the measles, mumps, and rubella (MMR) vaccine.

Main Methods:

  • A controlled phase II trial in 210 toddlers (12-15 months) in the Philippines.
  • Participants received CYD-TDV with MMR concomitantly or 1 month prior, or received active control vaccines.
  • Safety, reactogenicity, and immunogenicity (dengue and MMR) were assessed post-vaccination.

Main Results:

  • CYD-TDV demonstrated an acceptable safety profile with no major safety concerns.
  • Fever was more frequent with CYD-TDV and MMR coadministration but reactogenicity did not increase with subsequent doses.
  • The vaccine induced a balanced antibody response to all four dengue serotypes and did not affect MMR immunogenicity.

Conclusions:

  • The CYD-TDV vaccine is safe and immunogenic in toddlers.
  • Coadministration with the MMR vaccine is feasible and does not compromise the immunogenicity of either vaccine.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.6K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
124
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
868
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
55
Cross-reactivity00:42

Cross-reactivity

Overview
34.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K